Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0EBFGG)
| ADC Name |
IBI3009
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
IBI3009; RG6810
Click to Show/Hide
|
|||||
| Organization |
Innovent Biologics (Originator);Roche (Top20 MNC)
|
|||||
| Drug Status |
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Anti-DLL3 mAb
|
Antibody Info | ||||
| Antigen Name |
Delta-like protein 3 (DLL3)
|
Antigen Info | ||||
| Payload Name |
NT1
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC